Tue 18'th Sep 2018
Rocket Pharmaceuticals Inc Stock Analysis
Technical stock analysis for Tue 18'th Sep 2018
|Shorts||19.60% ( 2018-08-31 )|
Rocket Pharmaceuticals Inc gained 2.33% in the last trading day, rising from $22.27 to $22.79 The price has fallen in 6 of the last 10 days and is down by -3.51% for this period. Volume fell in the last day by -234 194 shares, and in total, 152 210 shares bought and sold for approximately $3.47 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.
Rocket Pharmaceuticals Inc lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 17.96% during the next 3 months and, with 90% probability hold a price between $24.56 and $30.29 at the end of this period.
Only positive signals in the chart today. Rocket Pharmaceuticals Inc holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $24.00. On a fall, the stock will find some support from the long-term average at approximately $22.09. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. A buy signal was issued from a pivot bottom point on Monday September 17, 2018, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely.
Relative Strength Index (RSI)
RSI14 is 53 and the stock is currently not being overbought or oversold
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $20.87 and $20.61.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Rocket Pharmaceuticals Inc finds support just below today's level at $20.87. If this is broken, then the next support from accumulated volume will be at $20.61 and $20.42.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.77 between high and low, or 3.46%. For the last week, the stock has had a daily average volatility of 7.08%.
Our recommended stoploss: $21.59 (-5.27%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 1 days ago.)
Very Low Low Medium High Very High
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term.Click for Top 5 Buy Candidates
|RCKT $22.79 $0.52(2.33%)|
RCKT is up $0.52 today, but where's it headed in October?
|Zacks Investment Research is releasing its prediction for RCKT based on the 1-3 month system that more than doubles the S&P 500.
Click here – the RCKT analysis is free »